News Conference News ESC 2019 CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients Shelley Wood September 03, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Daily News Infection During CV Hospital Stays Tied to Higher Costs, Greater Death Risk Marcus A. Banks July 24, 2019
News Industry News Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study July 22, 2019
News Daily News Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients Michael O'Riordan July 19, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Daily News Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues Todd Neale June 26, 2019
News Conference News EAS 2019 Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis Michael O'Riordan May 28, 2019
News Conference News HRS 2019 Even in the DOAC Era, Women Less Likely Than Men to Receive Anticoagulation for A-fib Todd Neale May 17, 2019
News Daily News Familial Hypercholesterolemia Seen in 10% of Young MI Patients Michael O'Riordan May 15, 2019
News Daily News Bariatric Surgery Linked to Survival Advantage After MI and CVA Michael O'Riordan May 13, 2019
News Conference News HRS 2019 Grapefruit Juice Prolongs QT Interval, but How Much Does It Matter? Todd Neale May 13, 2019
News Conference News HRS 2019 ERADICATE-AF: Could Add-on Renal Denervation Give A-fib Ablation a Boost? Todd Neale May 10, 2019
News Daily News In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients L.A. McKeown May 07, 2019
News Daily News Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure Michael O'Riordan May 06, 2019
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019
News Daily News PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction Michael O'Riordan April 29, 2019
News Daily News Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations L.A. McKeown April 23, 2019